LIFEVANTAGE CORP Non Peo Neo Avg Comp Actually Paid Amt
LIFEVANTAGE CORP (LFVN) reported Non Peo Neo Avg Comp Actually Paid Amt of $288.43 thousand for the 12-month period ending 2026-06-30, per its DEF 14A filed 2026-09-18.
Financial Statements › Cash Flow › Other Cash Flow Items
ecd:NonPeoNeoAvgCompActuallyPaidAmt · last filed 2026-09-18
| Period end | Non Peo Neo Avg Comp Actually Paid Amt 12 month |
|---|---|
| 2026-06-30 | $288.43K DEF 14A · filed 2026-09-18 |
| 2025-06-30 | $1.48M DEF 14A · filed 2026-09-18 |
| 2024-06-30 | $853.89K DEF 14A · filed 2026-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |